Literature DB >> 7504688

Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.

N Kerlero de Rosbo1, R Milo, M B Lees, D Burger, C C Bernard, A Ben-Nun.   

Abstract

Although T cell responses to the quantitatively major myelin proteins, myelin basic protein (MBP) and proteolipid protein (PLP), are likely to be of importance in the course of multiple sclerosis (MS), cell-mediated autoimmune responses to other myelin antigens, in particular quantitatively minor myelin antigens, such as myelin-associated glycoprotein (MAG) and the central nervous system-specific myelin oligodendrocyte glycoprotein (MOG), could also play a prevalent role in disease initiation or progression. Highly purified myelin antigens were used in this study to assess cell-mediated immune response to MOG in MS patients, in the context of the reactivity to other myelin antigens, MBP, PLP, and MAG. The greatest incidence of proliferative response by MS peripheral blood lymphocytes was to MOG, as 12 of 24 patients tested reacted and, of these, 8 reacted to MOG exclusively. In contrast, only 1 control individual of 16 tested reacted positively to MOG. The incidence of responses to MBP, PLP, and MAG did not differ greatly between MS patients and control individuals. A predominant T cell reactivity to MOG in MS suggests an important role for cell-mediated immune response to this antigen in the pathogenesis of MS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504688      PMCID: PMC288456          DOI: 10.1172/JCI116875

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Human T lymphocyte response to myelin basic protein: selection of T lymphocyte lines from MBP-responsive donors.

Authors:  A A Vandenbark; Y K Chou; D Bourdette; R Whitham; J Chilgren; C H Chou; G Konat; G Hashim; M Vainiene; H Offner
Journal:  J Neurosci Res       Date:  1989-05       Impact factor: 4.164

2.  T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.

Authors:  K Ota; M Matsui; E L Milford; G A Mackin; H L Weiner; D A Hafler
Journal:  Nature       Date:  1990-07-12       Impact factor: 49.962

3.  Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein.

Authors:  N Kerlero de Rosbo; P Honegger; H Lassmann; J M Matthieu
Journal:  J Neurochem       Date:  1990-08       Impact factor: 5.372

4.  The epitope(s) recognized by HNK-1 antibody and IgM paraprotein in neuropathy is present on several N-linked oligosaccharide structures on human P0 and myelin-associated glycoprotein.

Authors:  D Burger; M Simon; G Perruisseau; A J Steck
Journal:  J Neurochem       Date:  1990-05       Impact factor: 5.372

5.  Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls.

Authors:  J B Sun; T Olsson; W Z Wang; B G Xiao; V Kostulas; S Fredrikson; H P Ekre; H Link
Journal:  Eur J Immunol       Date:  1991-06       Impact factor: 5.532

6.  Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides.

Authors:  J L Trotter; W F Hickey; R C van der Veen; L Sulze
Journal:  J Neuroimmunol       Date:  1991-07       Impact factor: 3.478

7.  Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides.

Authors:  V K Kuchroo; R A Sobel; T Yamamura; E Greenfield; M E Dorf; M B Lees
Journal:  Pathobiology       Date:  1991       Impact factor: 4.342

8.  T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.

Authors:  J Sun; H Link; T Olsson; B G Xiao; G Andersson; H P Ekre; C Linington; P Diener
Journal:  J Immunol       Date:  1991-03-01       Impact factor: 5.422

9.  Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis.

Authors:  D A Hafler; D S Benjamin; J Burks; H L Weiner
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

10.  T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis.

Authors:  L L Perry; E Barzaga-Gilbert; J L Trotter
Journal:  J Neuroimmunol       Date:  1991-07       Impact factor: 3.478

View more
  67 in total

1.  Skewed autoantibody reactivity to the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis.

Authors:  Maria V Tejada-Simon; Jian Hong; Victor M Rivera; Jingwu Z Zhang
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Evoked potential and behavioral outcomes for experimental autoimmune encephalomyelitis in Lewis rats.

Authors:  Angelo H All; Gracee Agrawal; Piotr Walczak; Anil Maybhate; Jeff W M Bulte; Douglas A Kerr
Journal:  Neurol Sci       Date:  2010-05-28       Impact factor: 3.307

Review 3.  Systemic immunomodulation of autoimmune disease using MHC-derived recombinant TCR ligands.

Authors:  Gregory G Burrows
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2005-04

Review 4.  Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Authors:  Anne H Cross; Jennifer L Stark
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Regional Distribution of CNS Antigens Differentially Determines T-Cell Mediated Neuroinflammation in a CX3CR1-Dependent Manner.

Authors:  Aditya Rayasam; Julie A Kijak; McKenna Dallmann; Martin Hsu; Nicole Zindl; Anders Lindstedt; Leah Steinmetz; Jeffrey S Harding; Melissa G Harris; Jozsef Karman; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Neurosci       Date:  2018-06-29       Impact factor: 6.167

6.  Eae19, a new locus on rat chromosome 15 regulating experimental autoimmune encephalomyelitis.

Authors:  Jian Rong Sheng; Maja Jagodic; Ingrid Dahlman; Kristina Becanovic; Rita Nohra; Monica Marta; Ellen Iacobaeus; Tomas Olsson; Erik Wallström
Journal:  Genetics       Date:  2005-02-16       Impact factor: 4.562

Review 7.  Oral tolerance and the treatment of rheumatoid arthritis.

Authors:  H L Weiner; Y Komagata
Journal:  Springer Semin Immunopathol       Date:  1998

8.  Production and crystallization of a panel of structure-based mutants of the human myelin peripheral membrane protein P2.

Authors:  Mari Lehtimäki; Saara Laulumaa; Salla Ruskamo; Petri Kursula
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-10-30

9.  Physical mapping of the human and mouse MOG gene at the distal end of the MHC class Ib region.

Authors:  D Pham-Dinh; E P Jones; G Pitiot; B Della Gaspera; P Daubas; J Mallet; D Le Paslier; K Fischer Lindahl; A Dautigny
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

Review 10.  Chipping away at diagnostics for neurodegenerative diseases.

Authors:  Clemens R Scherzer
Journal:  Neurobiol Dis       Date:  2009-03-10       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.